GO:0015889 cobalamin transport: Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015889 cobalamin transport describes the directed movement of vitamin B12 (cobalamin) into, out of, or within cells via transporters or pores.
• Cobalamin is a water-soluble corrinoid with a central cobalt atom, essential for DNA synthesis and neurological function.
• Transport involves multiple steps: intestinal uptake, blood transport by transcobalamin, and cellular uptake via receptor-mediated endocytosis.
• Defects in cobalamin transport cause deficiency syndromes including megaloblastic anemia and neurological disorders.
• Key genes include LMBRD1, ABCD4, TCN2, CUBN, and AMN, each with distinct roles in absorption and cellular trafficking.
• CRISPR knockout and knock-in models are powerful tools to dissect cobalamin transport mechanisms and disease variants.
Description
Cobalamin (vitamin B12) is a water-soluble vitamin characterized by a corrin nucleus containing a cobalt atom. Its transport across biological membranes is essential for cellular function, as cobalamin serves as a cofactor for methionine synthase and methylmalonyl-CoA mutase. The Gene Ontology term GO:0015889, cobalamin transport, encompasses the directed movement of cobalamin into, out of, or within a cell, or between cells, by means of transporters or pores. This process is critical for normal physiology, and its disruption leads to severe hematological and neurological disorders. Researchers study cobalamin transport to understand nutrient absorption, cellular uptake, and the molecular basis of related diseases. The transport system involves a complex interplay of binding proteins, receptors, and ATP-driven transporters. Advances in CRISPR gene editing have enabled precise modeling of transport defects, accelerating therapeutic development. This article provides a comprehensive overview of cobalamin transport, integrating authoritative GO definitions with published literature. It covers the molecular mechanisms, key genes, disease associations, and research methodologies, offering a resource for biomedical researchers and AI-driven knowledge retrieval.
cobalamin transport At A Glance
| GO ID | GO:0015889 |
|---|---|
| GO term | cobalamin transport |
| Ontology | biological_process |
| Synonym | vitamin B12 transport |
| Major function | Directed movement of cobalamin across membranes and between cells |
| Key transporters | ABCD4, LMBRD1, TCN2, CUBN, AMN |
| Associated diseases | Vitamin B12 deficiency, megaloblastic anemia, neurological disorders |
| Research methods | CRISPR knockout, knock-in, transport assays, proteomics |
What Is GO:0015889?
GO:0015889 cobalamin transport is defined as the directed movement of cobalamin (vitamin B12), a water-soluble vitamin containing a corrin nucleus with a cobalt atom, into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This biological process includes intestinal absorption, blood circulation via transport proteins, and cellular uptake through receptor-mediated endocytosis and lysosomal export.
Why Is cobalamin transport Important in Cell Biology?
Cobalamin transport is vital for human health because cobalamin is required for DNA synthesis, red blood cell formation, and maintenance of the nervous system. Defects in transport proteins lead to vitamin B12 deficiency, which manifests as megaloblastic anemia, neuropathy, and cognitive decline. Understanding the molecular mechanisms of cobalamin transport is essential for diagnosing and treating related disorders, and for developing targeted therapies.
• Cobalamin is a cofactor for methionine synthase and methylmalonyl-CoA mutase, linking transport to one-carbon metabolism and energy production.
• Impaired intestinal absorption due to CUBN or AMN mutations causes Imerslund-Gräsbeck syndrome.
• Defective lysosomal export via ABCD4 or LMBRD1 leads to cobalamin trafficking disorders.
• Transcobalamin II (TCN2) deficiency results in severe early-onset megaloblastic anemia.
• Elevated cobalamin levels in blood can indicate underlying malignancies or liver disease.
• Cobalamin transport is a target for antimicrobial drug development in mycobacteria.
• CRISPR screens can identify novel genes regulating cobalamin uptake and efflux.
• Studying transport mechanisms aids in designing vitamin B12-based drug delivery systems.
What Happens During cobalamin transport?
Intestinal absorption and blood transport
In simple terms: Vitamin B12 from food is absorbed in the gut and carried in the blood by special proteins.
Dietary cobalamin is released from food in the stomach and binds to haptocorrin; in the intestine, it is transferred to intrinsic factor (IF). The IF-cobalamin complex is recognized by the cubilin-amnionless (CUBN-AMN) receptor on ileal enterocytes and internalized via endocytosis. After lysosomal release, cobalamin exits enterocytes into the bloodstream, where it binds to transcobalamin II (TCN2) for delivery to tissues.
Cellular uptake via receptor-mediated endocytosis
In simple terms: Cells take in vitamin B12 by engulfing it with the help of a receptor.
The TCN2-cobalamin complex binds to the transcobalamin receptor (CD320) on the cell surface, triggering endocytosis. Inside the endosome, the complex dissociates, and cobalamin is transported into the lysosome. From the lysosome, cobalamin must be exported to the cytoplasm by the ATP-binding cassette transporter ABCD4, assisted by LMBRD1.
Lysosomal export and cytosolic delivery
In simple terms: Vitamin B12 must escape the lysosome to reach the cell's main compartment.
ABCD4, a lysosomal membrane protein, uses ATP hydrolysis to pump cobalamin out of the lysosome. LMBRD1 (LMBD1) is thought to facilitate this process, possibly by presenting cobalamin to ABCD4. Mutations in ABCD4 or LMBRD1 cause cobalamin trafficking defects, leading to functional deficiency.
Prokaryotic cobalamin transport
In simple terms: Bacteria also need vitamin B12 and use specialized pumps to import it.
In prokaryotes, cobalamin is transported by ABC transporters such as BtuCD in Escherichia coli and BacA in mycobacteria. BacA is a bidirectional ATP-driven transporter that can both import and export cobalamin, highlighting mechanistic diversity. These transporters are potential antibiotic targets.
Key Genes Involved in GO:0015889 cobalamin transport
The following genes encode proteins directly involved in cobalamin transport across membranes and between cells.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CUBN | Cubilin receptor for IF-cobalamin uptake in ileum | Mutations cause Imerslund-Gräsbeck syndrome |
| AMN | Amnionless, partner of cubilin | Defects lead to intestinal cobalamin malabsorption |
| TCN2 | Transcobalamin II, blood carrier | Deficiency causes severe anemia |
| CD320 | Transcobalamin receptor for cellular uptake | Target for studying tissue delivery |
| ABCD4 | Lysosomal exporter of cobalamin | Mutations cause cblJ defect |
| LMBRD1 | Lysosomal membrane protein assisting export | Mutations cause cblF defect |
| BtuCD | E. coli ABC transporter for cobalamin | Model for transport mechanism |
| BacA | Mycobacterial bidirectional transporter | Drug target in tuberculosis |
| TCN1 | Haptocorrin, salivary carrier | Role in oral cobalamin binding |
| IF | Intrinsic factor, gastric carrier | Essential for ileal absorption |
| MTHFR | Methionine synthase, cobalamin-dependent | Links transport to one-carbon metabolism |
| MUT | Methylmalonyl-CoA mutase, cobalamin-dependent | Defects cause methylmalonic acidemia |
| CD320 | Transcobalamin receptor | Mediates cellular uptake |
| ATP6AP1 | Accessory protein for lysosomal transport | Potential regulator |
| CLN3 | Lysosomal membrane protein | May influence cobalamin trafficking |
| SLC46A1 | Heme carrier, possible cobalamin transporter | Emerging role |
| ABCC1 | Multidrug resistance protein | Potential cobalamin efflux |
How Is cobalamin transport Regulated?
Cobalamin transport is regulated at multiple levels. Intestinal absorption is influenced by intrinsic factor availability and cubilin receptor expression. Cellular uptake via CD320 is downregulated by its soluble form, which competes for TCN2-cobalamin. Lysosomal export by ABCD4 is ATP-dependent and may be regulated by LMBRD1 levels. In prokaryotes, BacA expression is controlled by cobalamin availability and stress responses. Elevated serum cobalamin can result from increased transcobalamin production or release from damaged tissues.
cobalamin transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TCN2 | Transcobalamin II deficiency, megaloblastic anemia | Knockout HEK293 cells, patient iPSCs |
| CUBN | Imerslund-Gräsbeck syndrome | Intestinal organoids, KO mice |
| AMN | Imerslund-Gräsbeck syndrome | KO zebrafish, cell lines |
| ABCD4 | cblJ defect, lysosomal cobalamin accumulation | Knockout HeLa cells, patient fibroblasts |
| LMBRD1 | cblF defect, developmental delay | KO HEK293, iPSC-derived neurons |
Vitamin B12 deficiency and megaloblastic anemia
Impaired cobalamin transport due to TCN2, CUBN, or AMN mutations leads to vitamin B12 deficiency, characterized by megaloblastic anemia and neurological symptoms. Early diagnosis and treatment with parenteral cobalamin are critical.
Imerslund-Gräsbeck syndrome
Mutations in CUBN or AMN cause Imerslund-Gräsbeck syndrome, a rare autosomal recessive disorder featuring selective intestinal malabsorption of cobalamin and proteinuria. This condition highlights the essential role of the cubilin-amnionless receptor complex.
Lysosomal transport defects (cblF and cblJ)
Defects in LMBRD1 (cblF) or ABCD4 (cblJ) impair lysosomal export of cobalamin, causing accumulation in lysosomes and functional deficiency. Patients present with developmental delay, stomatitis, and hematological abnormalities.
Elevated cobalamin in cancer and liver disease
Elevated serum cobalamin levels can be a marker of myeloproliferative disorders, liver disease, or renal failure, reflecting increased transcobalamin release or decreased clearance. This underscores the need to interpret cobalamin levels in clinical context.
From cobalamin transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate cobalamin uptake? | CRISPR knockout in HeLa or HEK293 cells |
| Does mutation Y affect transport activity? | Point mutation knock-in in cell lines |
| Can we visualize cobalamin trafficking? | Tagged knock-in of ABCD4 with GFP |
| Does overexpression of TCN2 increase delivery? | Overexpression in hepatocytes |
| Which genes are essential for transport? | Genome-wide CRISPR library screening |
| How does BacA transport cobalamin? | Bacterial knockout and transport assays |
How to Study the cobalamin transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled cobalamin uptake | Transport rate and capacity | Diagnosing transport defects |
| CRISPR knockout screening | Gene essentiality for transport | Identifying novel regulators |
| Co-immunoprecipitation | Protein-protein interactions | Studying ABCD4-LMBRD1 complex |
| Live-cell imaging | Subcellular localization and dynamics | Visualizing lysosomal export |
| RNA-seq | Transcriptional changes | Response to cobalamin availability |
| Proteomics | Protein expression and modifications | Mapping transport machinery |
| Transport assays in bacteria | BacA activity | Antibiotic target validation |
Transport assays with radiolabeled cobalamin
Radiolabeled (57Co) cobalamin is used to measure uptake and efflux in cells and tissues. This method quantifies transport kinetics and identifies defects in patient samples.
CRISPR screening for transport regulators
Genome-wide CRISPR knockout libraries can identify genes required for cobalamin uptake or toxicity. Hits are validated by individual knockouts and transport assays.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry reveals protein complexes involved in cobalamin transport, such as ABCD4-LMBRD1. This approach uncovers novel components and regulatory mechanisms.
Imaging and subcellular localization
Fluorescently tagged cobalamin or transport proteins enable live-cell imaging of trafficking pathways. Confocal microscopy visualizes lysosomal export and cytosolic delivery.
How CRISPR Can Be Used to Study GO:0015889 cobalamin transport
Knockout
CRISPR knockout of transport genes such as ABCD4 or LMBRD1 in cell lines abolishes cobalamin export, causing lysosomal accumulation. These models mimic patient defects and are used to test therapeutic rescue.
Point Mutation
Introducing patient-specific point mutations (e.g., in ABCD4) via CRISPR knock-in allows precise assessment of functional impact on transport activity. This approach validates variant pathogenicity.
Knock-in
Tagged knock-in of transport proteins with fluorescent or affinity tags enables visualization and purification of native complexes. This helps define dynamic trafficking and interaction partners.
Overexpression
Overexpression of TCN2 or CD320 in cell lines increases cobalamin uptake and can model elevated serum cobalamin states. This is useful for studying transport saturation and delivery.
How EDITGENE Supports cobalamin transport Research
Researchers studying cobalamin transport-related genes often need to determine whether a candidate gene is causally involved in uptake, efflux, or trafficking. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for cobalamin transport research.
Frequently Asked Questions About cobalamin transport
What is cobalamin transport?
Cobalamin transport (GO:0015889) is the directed movement of vitamin B12 into, out of, or within cells via transporters or pores.
What genes are involved in cobalamin transport?
Key genes include CUBN, AMN, TCN2, CD320, ABCD4, and LMBRD1, each mediating distinct steps of absorption, blood transport, and cellular uptake.
What diseases are linked to defective cobalamin transport?
Defects cause vitamin B12 deficiency, megaloblastic anemia, Imerslund-Gräsbeck syndrome, and lysosomal transport disorders (cblF, cblJ).
How is cobalamin transported into cells?
Cobalamin binds to transcobalamin II (TCN2) and is taken up via CD320 receptor-mediated endocytosis, then exported from lysosomes by ABCD4.
What is the role of ABCD4 in cobalamin transport?
ABCD4 is an ATP-binding cassette transporter that pumps cobalamin out of lysosomes; mutations cause cblJ defect.
Can CRISPR be used to study cobalamin transport?
Yes, CRISPR knockout and knock-in models are used to dissect gene function and model patient mutations in cobalamin transport.
What are the symptoms of cobalamin transport deficiency?
Symptoms include megaloblastic anemia, fatigue, neurological deficits, and developmental delay in severe cases.
How is cobalamin transport measured in the lab?
Radiolabeled cobalamin uptake assays, transport kinetics, and imaging of tagged proteins are common methods.
What is Imerslund-Gräsbeck syndrome?
A rare disorder caused by CUBN or AMN mutations, leading to selective intestinal cobalamin malabsorption and proteinuria.
Why is cobalamin transport important for bacteria?
Bacteria use transporters like BacA for cobalamin uptake, which is essential for metabolism and a potential antibiotic target.
Conclusion
Cobalamin transport (GO:0015889) is a fundamental biological process that ensures vitamin B12 delivery to cells, supporting DNA synthesis, red blood cell formation, and neurological function. Disruptions in transport proteins cause a spectrum of diseases, from anemia to lysosomal storage disorders. Advances in CRISPR gene editing and functional genomics are accelerating the discovery of new transport components and therapeutic strategies. EDITGENE's suite of CRISPR services empowers researchers to model transport defects precisely and translate findings into clinical applications.
References
- 1. Nijland M et al.. 2022. Membrane transport of cobalamin.. Vitam Horm 119:121-148 PMID: 35337617
- 2. Ermens AA et al.. 2003. Significance of elevated cobalamin (vitamin B12) levels in blood.. Clin Biochem 36(8):585-90 PMID: 14636871
- 3. Seetharam B et al.. 1982. Absorption and transport of cobalamin (vitamin B12).. Annu Rev Nutr 2:343-69 PMID: 6313022
- 4. Sennett C et al.. 1981. Transmembrane transport of cobalamin in prokaryotic and eukaryotic cells.. Annu Rev Biochem 50:1053-86 PMID: 6267986
- 5. Imai M et al.. 2024. Transmembrane helix 6 of ABCD4 is indispensable for cobalamin transport.. J Inherit Metab Dis 47(2):366-373 PMID: 38069516
- 6. Green R et al.. 2022. Vitamin B12 deficiency.. Vitam Horm 119:405-439 PMID: 35337628
- 7. Nijland M et al.. 2024. Bidirectional ATP-driven transport of cobalamin by the mycobacterial ABC transporter BacA.. Nat Commun 15(1):2626 PMID: 38521790
- 8. Alpers DH. 2016. Absorption and blood/cellular transport of folate and cobalamin: Pharmacokinetic and physiological considerations.. Biochimie 126:52-6 PMID: 26586110
